Active Ingredient History

  • Now
Barusiban (INN) is a non-peptide drug which is among the most potent and selective oxytocin receptor antagonists known. It was trialed by Ferring Pharmaceuticals as a treatment of preterm labor but failed to demonstrate effectiveness and was not pursued any further.   Wikipedia

  • SMILES: CC[C@@H](C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)CCSCC[C@H](NC(=O)[C@H](CC(=O)N)NC1=O)C(=O)N(C)[C@H](CO)CCCN)[C@@H](C)CC
  • Mol. Mass: 830.07
  • ALogP: 0.19
  • ChEMBL Molecule:
More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No
barusiban | fe200440 | fe-200440


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue